Xunlei Limited (XNET)

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	275	126	106	121	135	193
Market Cap Growth	186.28%	19.22%	-12.57%	-10.12%	-30.33%	-41.84%
Enterprise Value	29	-131	-128	-100	-78	-33
Last Close Price	4.41	1.99	1.62	1.82	2.01	2.89
PE Ratio	-	103.83	7.44	5.64	113.06	-
Forward PE	-	13.07	13.07	13.07	13.07	13.07
PS Ratio	0.84	0.39	0.29	0.35	0.56	1.04
PB Ratio	0.87	0.40	0.33	0.39	0.45	0.67
P/TBV Ratio	0.89	0.41	0.36	0.43	0.50	0.74
P/FCF Ratio	-	5.50	4.87	3.35	21.45	-
P/OCF Ratio	-	4.07	4.12	2.37	6.91	-
PEG Ratio	-	1.60	1.60	1.60	1.60	1.60
EV/Sales Ratio	0.09	-	-	-	-	-
EV/EBITDA Ratio	4.92	-	-	-	-	-
Debt / Equity Ratio	0.09	0.09	0.07	0.11	0.07	0.08
Debt / EBITDA Ratio	0.27	0.26	0.19	0.27	0.23	0.38
Debt / FCF Ratio	-	1.29	1.06	0.90	3.22	-
Asset Turnover	0.69	0.69	0.78	0.76	0.56	0.44
Inventory Turnover	110.66	89.56	149.96	219.84	76.79	25.51
Quick Ratio	2.48	2.82	2.49	2.52	2.32	2.80
Current Ratio	2.60	2.86	2.56	2.59	2.45	2.93
Return on Equity (ROE)	-1.22%	0.21%	4.52%	7.00%	0.37%	-4.83%
Return on Assets (ROA)	-0.11%	0.67%	-0.22%	1.39%	-0.48%	-2.98%
Return on Capital (ROIC)	-0.16%	0.91%	-0.29%	1.90%	-0.66%	-3.98%
Return on Capital Employed (ROCE)	-	1.50%	-	3.00%	-	-
Earnings Yield	-1.17%	0.96%	13.44%	17.73%	0.88%	-7.16%
FCF Yield	-	18.19%	20.53%	29.86%	4.66%	-14.21%
Buyback Yield / Dilution	3.64%	2.36%	2.79%	-0.08%	0.43%	0.12%

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q